A Trial of LBL-024 Monotherapy, LBL-024 Combined With LBL-007 or Toripalimab in Patients With Advanced Melanoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Yu Chen
Fujian Cancer Hospital
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
15 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Fujian Cancer Hospital
Fuzhou, Fujian, China
Recruiting - Dermatology Hospital of Southern Medical University
Guangzhou, Guangdong, China
Not, yet, recruiting - Sun Yat-Sen University Cancer Center
Guangzhou, Guangdong, China
Recruiting - Guangxi Medical University Cancer Hospital
Nanning, Guangxi, China
Recruiting - Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Wuhan, Hubei, China
Recruiting - Nanjing Drum Tower Hospital
Nanjing, Jiangsu, China
Recruiting - the First Hospital of Jilin University
Changchun, Jilin, China
Not, yet, recruiting - Shandong Cancer Hospital
Jinan, Shandong, China
Recruiting - Fudan University Shanghai Cancer Center
Shanghai, Shanghai Municipality, China
Not, yet, recruiting - Shanxi Bethune Hospital
Taiyuan, Shanxi, China
Recruiting - the Second Affiliated Hospital of Xi'An Jiaotong University
Xi’an, Shanxi, China
Not, yet, recruiting - West China Hospital of Sichuan University
Chengdu, Sichuan, China
Recruiting - Tianjin Medical University Cancer Institute &hospital
Tianjin, Tianjin Municipality, China
Not, yet, recruiting - Yunnan Cancer Hospital
Kunming, Yunnan, China
Recruiting - Zhejiang Cancer Hospital
Hangzhou, Zhejiang, China
Not, yet, recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 5 Sept 2025
- Primary completion
- 30 Oct 2027
- Completion
- 30 Dec 2027
- Last update posted
- 18 May 2026
- Registered enrollment
- 200
- Registry id
- NCT07099430
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.